# BIOFLOW-III Belgium Satellite Registry

> **NCT01831336** · — · COMPLETED · sponsor: **Biotronik Belgium NV** · enrollment: 332 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01831336
- **Lead sponsor:** Biotronik Belgium NV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2017-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831336, "BIOFLOW-III Belgium Satellite Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01831336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*